Showing results (11-20 of 338) with videos related to
Sort By:
Pageof 34
Current Opinion in Rheumatology|April 7, 2007
Economic issues with new rheumatologic therapeuticsArthur KavanaughAdvances in Therapy|June 6, 2006
Anakinra (interleukin-1 receptor antagonist) has positive effects on function and quality of life in patients with rheumatoid arthritisArthur KavanaughRheumatic Diseases Clinics of North America|March 1, 2006
The pharmacoeconomics of newer therapeutics for rheumatic diseasesArthur KavanaughThe Journal of Allergy and Clinical Immunology|January 16, 2016
Alterations in immune function with biologic therapies for autoimmune diseaseMinyoung Her, Arthur KavanaughClinics in Geriatric Medicine|May 25, 2005
Rheumatic disease in the elderly: rheumatoid arthritisZuhre Tutuncu, Arthur KavanaughClinics in Dermatology|September 13, 2006
Rheumatoid arthritis in dermatologyTissa Hata, Arthur KavanaughRheumatic Diseases Clinics of North America|June 3, 2004
Consideration of the risk and treatment of tuberculosis in patients who have rheumatoid arthritis and receive biologic treatmentsJeffry Bieber, Arthur KavanaughClinical and Experimental Rheumatology|October 13, 2015
Trial design in psoriatic arthritis: what could be changed?Arthur Kavanaugh, Tristan BoydExpert Opinion on Therapeutic Targets|November 22, 2007
Tumor necrosis factor as a therapeutic target of rheumatologic diseaseChristoph Ackermann, Arthur KavanaughPageof 34